65
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Concomitant EBV encoded RNA positive cutaneous nasal-type natural killer-cell lymphoma and EBV encoded RNA negative nasopharyngeal carcinoma

, , &
Pages 1543-1544 | Received 12 May 2009, Accepted 08 Jun 2009, Published online: 15 Sep 2009

References

  • Jaffe E S, Harris N L, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lympohid tissue. Tumours of haematopoietic and lymphoid tissues, World Health Organization classification of tumours. IARC Press, Lyon. 200: 121–253
  • Yeh K H, Lien H C, Hsu S M, et al. Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma. Am J Hematol 1999; 60: 161–163
  • Au W Y, Kwong Y L, Chan A C. Scrotal skin ulcer in a patient with a previous tonsillectomy because of natural killer cell lymphoma. Am J Dermatopathol 1998; 20: 582–585
  • Chim C S, Au W Y, Shek T W, et al. Primary CD56 positive lymphomas of the gastrointestinal tract. Cancer 2001; 91: 525–533
  • Au W Y, Shek W H, Nicholls J, et al. T-cell intravascular lymphomatosis (angiotropic large cell lymphoma): association with Epstein–Barr viral infection. Histopathology 1997; 31: 563–567
  • Yip K W, Shi W, Pintilie M, et al. Prognostic significance of the Epstein–Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin Cancer Res 2006; 12: 5726–5732

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.